Anti-Human CXCR4 (Clone 12G5) - APC

Leinco Technologies
Product Code: LEI-C863
Product Group: Primary Antibodies
CodeSizePrice
LEI-C863-50ug50 ug£307.00
Quantity:
LEI-C863-100ug100 ug£323.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Mouse
Antibody Isotype: IgG2a κ
Antibody Clonality: Monoclonal
Antibody Clone: 12G5
Regulatory Status: RUO
Target Species: Human
Application: Flow Cytometry
Shipping:
2-8°C
Storage:
This Allophyc°Cyanin (APC) conjugate is stable when stored at 2-8°C. Do not freeze.

Further Information

Antigen Distribution:
CXCR4 is expressed in various organs including ovary, bone marrow, kidney, lung, small intestine, spleen, lymph nodes, brain, stomach, liver, thymus, heart, and pancreas as well as on the surface of endothelial mature and precursor cells and pericytes.
Concentration:
0.2 mg/ml
Conjugate/Tag/Label:
Allophycocyanin (APC)
Format:
This Allophycocyanin (APC) conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Formulation:
This Allophycocyanin (APC) conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Immunogen:
CP-MAC-infected Sup-T1 cells
Long Description:
CXCR4 is a G-protein coupled receptor that binds the chemokine CXCL121. Chemokines are small 8-12 kDa proteins that mediate cell migration and arrest, homing and trafficking of leukocytes in bone marrow and lymphoid organs, tissue formation, cytoskeletal rearrangement, and immune cell recruitment to inflammation. Additionally, chemokines are expressed by cancer cells, where they enhance tumor angiogenesis and development. CXCR4 is the chemokine receptor most abundantly expressed2 and most frequently detected3 in various cancer types, being present in malignant cell subpopulations in primary tumors as well as sites of metastasis. CXCR4 is involved in tumor cell proliferation and migration2 and is involved in leukocyte chemotaxis in several autoimmune diseases1. CXCR4 also acts as an alternative receptor for some isolates of HIV-2 in the absence of CD44. CXCR4 expression is regulated by HIF-1α, IL-5, IFN-γ, TGF-β, and IL-17A1. 12G5 was produced by immunizing Balb/c mice with CP-MAC-infected Sup-T1 cells4. Hybridomas were generated and screened for the ability to inhibit CP-MAC-induced syncytium induction on Sup-T1 cells. 12G5 binds specifically to both human and nonhuman cells that express recombinant CXCR44. 12G5 inhibits CD4-independent infection by some HIV-2 isolates, and preincubating cells with 12G5 abolishes syncytium formation. HIV-2/vcp-infected cells display a marked and selective reduction in 12G5 binding. 12G5 also inhibits induction of cell-to-cell fusion of CXCR4+ RD/CD4 cells by HIV-1 and HIV-2 strains5.
NCBI Gene:
7852
Target:
CXCR4

References

1. Mousavi A. Immunol Lett. 217:91-115. 2020. 2. Barbieri F, Bajetto A, Thellung S, et al. Expert Opin Drug Discov. 11(11):1093-1109. 2016. 3. Bajetto A, Barbieri F, Dorcaratto A, et al. Neurochem Int. 49(5):423-432. 2006. 4. Endres MJ, Clapham PR, Marsh M, et al. Cell. 87(4):745-756. 1996. 5. McKnight A, Wilkinson D, Simmons G, et al. J Virol. 71(2):1692-1696. 1997. 6. Fischer T, Nagel F, Jacobs S, et al. PLoS One. 3(12):e4069. 2008. 7. Volin MV, Joseph L, Shockley MS, et al. Biochem Biophys Res Commun. 242(1):46-53. 1998. 8. Berndt C, M?pps B, Angerm?ller S, et al. Proc Natl Acad Sci U S A. 95(21):12556-12561. 1998. 9. Ullrich CK, Groopman JE, Ganju RK. Blood. 96(4):1438-1442. 2000. 10. Murga M, Fernandez-Capetillo O, Tosato G. Blood. 105(5):1992-1999. 2005.

Related Products

Product NameProduct CodeSupplier 
Anti-Human CXCR4 (Clone 12G5) - Purified in vivo GOLD™ Functional GradeLEI-C850Leinco Technologies Summary Details
Anti-Human CXCR4 (Clone 12G5) - PurifiedLEI-C861Leinco Technologies Summary Details
Anti-Human CXCR4 (Clone 12G5) - BiotinLEI-C862Leinco Technologies Summary Details